Similarly, in the rodent models of focal cerebral ischemia or excitotoxic damage induced by NMDA-receptor agonist, with IL-1RA treatment, the neuroprotective effects were substantiated [44, 45]. This evidence concerns the gene IL1R1 and brain ischemia.